“In states with more mature cannabis markets, such as Colorado and California, Green Thumb believes there are enough cultivators available and purchases cannabis from third parties,” says Inton. Share your opinion and gain insight from other stock traders and investors. Click here to find out more about our partners. On this news, Green Thumb's stock price fell $3.40 per share or 11.83%, to close at $25.35 per share on March 30, 2021. The Quantitative Fair Value Estimate is calculated daily. Similar to fellow U.S. cannabis giant, Curaleaf (CURA), fourth-quarter results were a little weaker than the 3rd quarter’s sequential growth. American cannabis pure-play, Green Thumb Industries (GTII) is riding the wave of state legalizations with faster top-line and profit growth than we expected. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Green Thumb’s state-picking prowess helps make up for the disadvantage of not operating internationally. Information about your device and Internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. Terms of Use        Privacy Policy        Cookies, The Morningstar Star Rating for Stocks is assigned based on an analyst's estimate of a stocks fair value. Green Thumb Industries Inc (CNSX:GTII, OTCMKTS:GTBIF) is one of the most compelling U.S. pot stocks out there. Not really. “As a large shareholder, he is incentivized to maximize long-term company performance.”. You can change your choices at any time by visiting Your Privacy Controls. Green Thumb Industries Stock at Record Levels & Just Getting Started. “Eventually, we expect federal law will be changed to allow states to choose the legality of cannabis within their borders,” says Inton forecasting nearly 25% average annual growth for the U.S. recreational market and more than 10% for the medical market through 2030. Pay-to-Play or Plain Lobbying? For detail information about the Quantiative Fair Value Estimate, please visit here, SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk. We’ve increased our fair value estimates to $62 per share, up from $40 per share. CHICAGO and VANCOUVER, British Columbia, March 17, 2021 (GLOBE NEWSWIRE) - Green Thumb Industries Inc. (“Green Thumb,” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today reported its financial results for the fourth quarter and full-year ended December 31, 2020. © Copyright 2021 Morningstar, Inc. All rights reserved. How Does the Green Thumb Grow?Green Thumb has a clever way of picking states to enter. Past performance of a security may or may not be sustained in future and is no indication of future performance. American cannabis pure-play, Green Thumb Industries is riding the wave of state legalizations with faster top-line and profit growth than we expected.Let’s see how it’s doing it and what to look forward to. “We think it would need to open cultivation internationally if it wants to compete in the global medical cannabis market - an unlikely event until federal laws are changed,” says Inton. We still expect continued, massive growth in Illinois, and we think Green Thumb is positioned well for potential legalization in Connecticut, New York and Pennsylvania after New Jersey’s decision to legalize. But investors would be mistaken to see this as weakness. We’re raising our fair value estimate – a bit - as we expect passenger levels abov... We raised our fair value for the cannabis giant taking on Canopy in Europe. The company was still up 13% sequentially and it increased its EBITDA by 23%. “Its growth strategy focuses on states with large populations and limited licenses, including Illinois, Massachusetts, New York, Florida, and Ohio,” says Inton. You currently DO NOT have javascript enabled, to view our site this must be enabled, fourth-quarter results were a little weaker, Get to Know Canada's Client Focused Reforms. A strategy that leads to pay day? Lots of U.S. Upside Left For the missed international opportunities, the U.S. still has the highest potential and offers the fastest growth of any market. Similar to fellow U.S. cannabis giant, Curaleaf (), fourth-quarter results were a little weaker than the 3 rd quarter’s sequential growth. CRON stock has benefited from key acquisitions thanks to strong backing from tobacco giant Altria ... Green Thumb made headlines when it acquired the vertically integrated For Success Holding Company. Green Thumb Industries is managed by great leadership, their execution is tremendous, and I see bright future toward legalization. Ads help us provide you with high quality content at no cost to you. Past performance of a security may or may not be sustained in future and is no indication of future performance. By clicking "Accept all", you agree that Verizon Media and our partners will store and/or access information on your device through the use of cookies and similar technologies and process your personal data to display personalised ads and content, for ad and content measurement, audience insights and product development. Morningstar assigns star ratings based on an analyst’s estimate of a stock's fair value. Until we know whether this is lobbying and political donations as usual, or something else, we’re focused on the fundamental facts that remain highly compelling: 12 states, 13 production facilities, 51 stores, 97 retail licenses, and six brands. A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn't. “It strategically operates in states with robust medical cannabis markets with momentum around future recreational legalization. And a lot of strategy. Learn about the companies most ready to grow in our latest Observer here. All information presented was current at the time of posting but may be superseded by subsequent disclosures. Follow him on Twitter @AndrewWillisCDN. For detail information about the Morningstar Star Rating for Stocks, please visit here, Quantitative Fair Value Estimate represents Morningstar’s estimate of the per share dollar amount that a company’s equity is worth today. “This helps reduce capital intensity for expansion without sacrificing exposure to widening legalization.”. This process culminates in a single-point star rating that is updated daily. Two of its large markets, Illinois and Massachusetts, have already legalized recreational use,” he adds. The speedy growth and state licenses that Green Thumb is gathering have garnered attention from investors – and, according to the Chicago Tribune, federal investigators for possible pay-to-play violations. You can select 'Manage settings' for more information and to manage your choices. With little detail and no official confirmations, it’s difficult to make an assessment, but there are some doubts. Green Thumb Industries decreased last week after the company reported a 134% increase in year-over-year December quarter sales to $177 million. He also notes that Kovler has a 26% economic stake in the firm and holds nearly 59% of the voting power. It is projection/opinion and not a statement of fact. Can ‘supercomputers on wheels’ save sales in a crypto downturn?  is Content Editor for Morningstar.ca. Green Thumb first learned of the alleged probe into supposed violations regarding obtaining licenses from a Chicago Tribune reporter who cited unnamed sources shortly before the … On this news, Green Thumb’s stock price fell $3.40 per share or 11.83%, to close at $25.35 per share on March 30, 2021 . Green Thumb, for its part, has donated to political campaigns and political action committees, or PACs, in the past. Investments in securities are subject to market and other risks. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. Investments in securities are subject to market and other risks. Find the latest THE GREEN ORGANIC DUTCHMAN HOLD (TGOD.TO) stock discussion in Yahoo Finance's forum. “It’s particularly hard to believe it would be pay-to-play as the issuances of licenses are a competitive process run by commissions, not politicians,” says sector director Kristoffer Inton, adding that he can’t really see how lobbying for legalization would be pay-to-play, as it opens the door for everybody, including the competition. It is a projection/opinion and not a statement of fact. Let’s see how it’s doing it and what to look forward to. The Quantitative Fair Value Estimate is based on a statistical model derived from the Fair Value Estimate Morningstar’s equity analysts assign to companies which includes a financial forecast of the company. Andrew Willis The CEO of Green Thumb, Ben Kovler seemed surprised by the allegations: Kovler refers to today’s cannabis industry as the end of Prohibition 2.0, says Inton. New changes reflect a higher minimum standard at which all advisors in Canada must operate, Tailwinds of growth for the industry ahead with reopening of economy, U.S. legalization, Companies that consistently increase their dividends tend to outperform, CPMS's Phil Dabo finds. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. The company assumes no duty to update the information to …